MY140638A - New heterocyclic compounds, which are active as inhibitors of beta-lactamases - Google Patents

New heterocyclic compounds, which are active as inhibitors of beta-lactamases

Info

Publication number: MY140638A
Authority: MY; Malaysia
Prior art keywords: lactamases; inhibitors; beta; active; heterocyclic compounds
Prior art date: 2002-01-28

Application number

MYPI20030260A

Other languages

English (en)

Inventor

Jozsef Aszodi

Claude Fromentin

Maxime Lampilas

David Alan Rowlands

Original Assignee

Novexel

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-01-28

Filing date

2003-01-27

Publication date

2010-01-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27619669&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY140638(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-01-27 Application filed by Novexel filed Critical Novexel

2010-01-15 Publication of MY140638A publication Critical patent/MY140638A/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

MYPI20030260A 2002-01-28 2003-01-27 New heterocyclic compounds, which are active as inhibitors of beta-lactamases MY140638A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0200951A FR2835186B1 (fr)	2002-01-28	2002-01-28	Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases

Publications (1)

Publication Number	Publication Date
MY140638A true MY140638A (en)	2010-01-15

Family

ID=27619669

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MYPI20030260A MY140638A (en)	2002-01-28	2003-01-27	New heterocyclic compounds, which are active as inhibitors of beta-lactamases

Country Status (45)

Country	Link
US (4)	US7612087B2 (es)
EP (2)	EP1480644B1 (es)
JP (1)	JP4472346B2 (es)
KR (1)	KR100979079B1 (es)
CN (3)	CN101406471A (es)
AR (2)	AR038234A1 (es)
AT (1)	ATE484281T1 (es)
AU (1)	AU2003214335B2 (es)
BE (1)	BE2016C069I2 (es)
BR (1)	BRPI0307267B8 (es)
CA (1)	CA2474043C (es)
CL (1)	CL2011000009A1 (es)
CO (1)	CO5601014A2 (es)
CR (2)	CR7387A (es)
CY (3)	CY1111061T1 (es)
DE (1)	DE60334527D1 (es)
DK (2)	DK1480644T3 (es)
EA (1)	EA007220B1 (es)
EC (1)	ECSP045193A (es)
ES (2)	ES2356813T3 (es)
FR (1)	FR2835186B1 (es)
HK (2)	HK1077205A1 (es)
HR (1)	HRP20040686B1 (es)
HU (1)	HUS1600055I1 (es)
IL (1)	IL163167A (es)
JO (1)	JO2646B1 (es)
LT (1)	LTC1480644I2 (es)
MA (1)	MA26351A1 (es)
MX (1)	MXPA04006621A (es)
MY (1)	MY140638A (es)
NL (1)	NL300847I2 (es)
NO (2)	NO335195B1 (es)
NZ (1)	NZ533936A (es)
OA (1)	OA12761A (es)
PE (1)	PE20030969A1 (es)
PL (1)	PL220725B1 (es)
PT (2)	PT1480644E (es)
RS (1)	RS52137B (es)
SI (2)	SI1480644T1 (es)
TN (1)	TNSN04137A1 (es)
TW (1)	TWI293071B (es)
UA (1)	UA80271C2 (es)
UY (1)	UY27626A1 (es)
WO (1)	WO2003063864A2 (es)
ZA (1)	ZA200405607B (es)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2812635B1 (fr) *	2000-08-01	2002-10-11	Aventis Pharma Sa	Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
FR2835186B1 (fr)	2002-01-28	2006-10-20	Aventis Pharma Sa	Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
FR2844273B1 (fr)	2002-09-05	2008-04-04	Aventis Pharma Sa	Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens.
US7439253B2 (en) *	2002-12-06	2008-10-21	Novexel	Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
FR2848210B1 (fr) *	2002-12-06	2007-10-19	Aventis Pharma Sa	Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens et inhibiteurs de beta-lactamases
US8900637B2 (en) *	2005-12-02	2014-12-02	Lupin Limited	Stable taste masked formulations of cephalosporins
CN103724330B (zh)	2005-12-07	2015-08-19	巴斯利尔药物股份公司	单环-内酰胺类抗生素与β-内酰胺酶抑制剂的有效的联合应用
EP2040698A4 (en) *	2006-07-14	2011-08-10	Shionogi & Co	OXIM CONNECTIONS AND ITS USE
MX2009004290A (es) *	2006-10-23	2009-07-27	Irm Llc	Inhibidores de proteasas de catepsina.
WO2008150470A1 (en) *	2007-05-31	2008-12-11	Shionogi & Co., Ltd.	Oxyimino compounds and the use thereof
FR2921060B1 (fr) *	2007-09-14	2012-06-15	Novexel	Nouveau procede de preparation d'une piperidine disubsituee et nouveaux intermediaires
PL2666774T3 (pl) *	2008-01-18	2015-06-30	Merck Sharp & Dohme	Inhibitory beta-laktamazy
US20110046101A1 (en) *	2008-03-17	2011-02-24	Dmitrienko Gary I	Bate-lactamase inhibitors
FR2930553B1 (fr) *	2008-04-29	2010-05-21	Novexel	Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment inhibiteurs de beta-lactamases
US8518934B2 (en) *	2008-06-11	2013-08-27	Shonogi & Co., Ltd.	Oxycarbamoyl compounds and the use thereof
FR2936798B1 (fr) *	2008-10-03	2012-09-28	Novexel	Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens.
FR2936951B1 (fr) *	2008-10-10	2010-12-03	Novexel	Nouvelles combinaisons de composes heterocycliques azotes antibacteriens avec d'autres composes antibacteriens et leur utilisation comme medicaments
FR2937034B1 (fr) *	2008-10-10	2012-11-23	Novexel	Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens
AU2014244235B2 (en) *	2009-10-09	2016-04-21	Pfizer Ireland Pharmaceuticals	Polymorphic and pseudopolymorphic forms of a pharmaceutical compound
FR2951171A1 (fr)	2009-10-09	2011-04-15	Novexel	Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation
DK3412676T3 (da)	2010-08-10	2020-05-04	Rempex Pharmaceuticals Inc	Cykliske borsyreesterderivater, fremgangsmåde til fremstillingen og terapeutiske anvendelser deraf
DK2657234T3 (da) *	2010-12-22	2017-02-20	Meiji Seika Pharma Co Ltd	Optisk aktivt diazabicyclooctanderivat og fremgangsmåde til fremstilling heraf
US8772490B2 (en)	2010-12-22	2014-07-08	Meiji Seika Pharma Co., Ltd.	Optically active diazabicyclooctane derivatives and process for preparing the same
EP2721005B1 (en)	2011-06-17	2015-11-25	AstraZeneca AB	Process for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
CA2833241C (en) *	2011-08-27	2015-05-12	Wockhardt Limited	1,6-diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections
US9102683B2 (en)	2011-08-29	2015-08-11	University Of Utah Research Foundation	Heterocyclic compounds
US20130053565A1 (en) *	2011-08-29	2013-02-28	University Of Utah Research Foundation	Substituted 3-piperidone compounds
WO2013033461A1 (en)	2011-08-31	2013-03-07	Rempex Pharmaceuticals, Inc.	Heterocyclic boronic acid ester derivatives and therapeutic uses thereof
US8969567B2 (en) *	2011-09-13	2015-03-03	Wockhardt Ltd.	Nitrogen containing compounds and their use
WO2013038330A1 (en) *	2011-09-13	2013-03-21	Wockhardt Limited	Nitrogen containing compounds and their use
US8796257B2 (en)	2011-12-02	2014-08-05	Naeja Pharmaceutical Inc.	Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
US9505761B2 (en)	2011-12-02	2016-11-29	Fedora Pharmaceuticals Inc.	Bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors
US8969570B2 (en)	2012-03-30	2015-03-03	Cubist Pharmaceuticals, Inc.	Beta-lactamase inhibitors
US8916709B2 (en)	2012-03-30	2014-12-23	Cubist Pharmaceuticals, Inc.	1,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors
EP2831069B1 (en)	2012-03-30	2017-07-12	Merck Sharp & Dohme Corp.	Isoxazole beta-lactamase inhibitors
US8940897B2 (en)	2012-03-30	2015-01-27	Cubist Pharmaceuticals, Inc.	1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors
AR090539A1 (es) *	2012-04-02	2014-11-19	Astrazeneca Ab	COMPUESTOS INHIBIDORES DE b LACTAMASA
US9156858B2 (en)	2012-05-23	2015-10-13	Rempex Pharmaceuticals, Inc.	Boronic acid derivatives and therapeutic uses thereof
AU2013268415B2 (en) *	2012-05-30	2017-05-25	Meiji Seika Pharma Co., Ltd.	Novel beta-lactamase inhibitor and method for producing same
US10561675B2 (en)	2012-06-06	2020-02-18	Rempex Pharmaceuticals, Inc.	Cyclic boronic acid ester derivatives and therapeutic uses thereof
EP3360877B1 (en) *	2012-08-25	2021-02-17	Wockhardt Limited	1,6- diazabicyclo [3,2,1]octan- 7- one derivatives and their use in the treatment of bacterial infections
UA111925C2 (uk)	2012-12-11	2016-06-24	Федора Фармасьютікалз Інк.	БІЦИКЛІЧНІ СПОЛУКИ ТА ЇХ ВИКОРИСТАННЯ ЯК АНТИБАКТЕРІАЛЬНИХ АГЕНТІВ ТА ІНГІБІТОРІВ β-ЛАКТАМАЗИ
EA201591003A1 (ru)	2013-01-04	2015-12-30	Ремпекс Фармасьютикалз, Инк.	Производные бороновой кислоты и их терапевтическое применение
CA2894892A1 (en)	2013-01-04	2014-07-10	Rempex Pharmaceuticals, Inc.	Boronic acid derivatives and therapeutic uses thereof
US9241947B2 (en)	2013-01-04	2016-01-26	Rempex Pharmaceuticals, Inc.	Boronic acid derivatives and therapeutic uses thereof
US9101638B2 (en)	2013-01-04	2015-08-11	Rempex Pharmaceuticals, Inc.	Boronic acid derivatives and therapeutic uses thereof
EP2970338A1 (en)	2013-03-14	2016-01-20	Merck Sharp & Dohme Corp.	Crystalline form of a beta-lactamase inhibitor
WO2015046207A1 (ja)	2013-09-24	2015-04-02	ＭｅｉｊｉＳｅｉｋａファルマ株式会社	ジアザビシクロオクタン誘導体の製造法とその中間体
WO2015051101A1 (en)	2013-10-02	2015-04-09	Cubist Pharmaceuticals, Inc.	B-lactamase inhibitor picoline salt
EP3613741A1 (en)	2013-10-08	2020-02-26	Meiji Seika Pharma Co., Ltd.	Preparation of a diazabicyclooctane derivative
WO2015125031A1 (en) *	2014-02-20	2015-08-27	Wockhardt Limited	Pharmaceutical combinations comprising antibacterial agents
CN103896936A (zh) *	2014-03-20	2014-07-02	西安交通大学	(5s,6r)氯唑西林青霉噻唑酸盐及其制备方法和应用
EP3139930B1 (en)	2014-05-05	2024-08-14	Melinta Therapeutics, Inc.	Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof
ES2750805T3 (es)	2014-05-05	2020-03-27	Rempex Pharmaceuticals Inc	Síntesis de sales de boronato y usos de las mismas
WO2015179308A1 (en)	2014-05-19	2015-11-26	Rempex Pharmaceuticals, Inc.	Boronic acid derivatives and therapeutic uses thereof
CN104059083B (zh) *	2014-05-27	2017-01-04	浙江工业大学	一种手性二环己内酰胺类化合物的不对称合成方法
EA201692301A1 (ru)	2014-07-01	2017-06-30	Ремпекс Фармасьютикалз, Инк.	Производные бороновой кислоты и их терапевтическое применение
PT3221313T (pt)	2014-11-17	2019-04-15	Entasis Therapeutics Ltd	Terapia combinada para tratamento de infecções bacterianas resistentes
WO2016081297A1 (en)	2014-11-18	2016-05-26	Rempex Pharmaceuticals, Inc.	Cyclic boronic acid ester derivatives and therapeutic uses thereof
MY190283A (en)	2014-12-05	2022-04-12	Meiji Seika Pharma Co Ltd	Method for producing crystals of diazabicyclooctane derivative and stable lyophilized preparation
US20180051041A1 (en)	2015-03-17	2018-02-22	Rempex Pharmaceuticals, Inc.	Boronic acid derivatives and therapeutic uses thereof
MX2017014080A (es) *	2015-05-07	2018-07-06	Mutabilis	Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
JP2018515481A (ja) *	2015-09-16	2018-06-14	シュアンチューファーマカンパニー，リミティド	β−ラクタマーゼ阻害剤とその利用
JP2018530553A (ja)	2015-10-02	2018-10-18	レゴケムバイオサイエンシズ，インク．ＬｅｇｏｃｈｅｍＢｉｏｓｃｉｅｎｃｅｓ，Ｉｎｃ．	β−ラクタマーゼを阻害するための組成物及び方法
WO2017156458A1 (en)	2016-03-11	2017-09-14	University Of South Florida	Beta-lactamase inhibitors, formulations, and uses thereof
ES2734773T3 (es)	2016-05-27	2019-12-11	Valoralia I Mas D Sl	Compuestos de dihidrooxadiazina para tratar infecciones y cáncer
CA3026582A1 (en)	2016-06-30	2018-01-04	Qpex Biopharma, Inc.	Boronic acid derivatives and therapeutic uses thereof
CN106279163A (zh) *	2016-08-12	2017-01-04	上海龙翔生物医药开发有限公司	一种合成阿维巴坦及其中间体光学异构体的方法
CN107789355B (zh) *	2016-09-07	2022-04-12	湘北威尔曼制药股份有限公司	含有哌拉西林的复方药物组合物及其应用
KR102537340B1 (ko)	2016-09-16	2023-05-26	엔타시스 테라퓨틱스 리미티드	베타-락타마제 억제제 화합물
JOP20190061A1 (ar) *	2016-09-28	2019-03-26	Novartis Ag	مثبطات بيتا-لاكتاماز
CN106699756B (zh) *	2016-12-30	2019-10-29	淄博鑫泉医药技术服务有限公司	β内酰胺酶抑制剂阿维巴坦的合成方法
EP3577117A1 (en)	2017-02-06	2019-12-11	Mutabilis	Novel heterocyclic compounds and their use in preventing or treating bacterial infections
TWI791018B (zh)	2017-05-08	2023-02-01	美商安特西醫療公司	治療細菌感染之化合物及方法
WO2018234962A1 (en)	2017-06-20	2018-12-27	Wockhardt Limited	PROCESS FOR O-SULFONATION OF 1,6-DIAZABICYCLO [3.2.1] OCTANE COMPOUNDS
CA3078627A1 (en)	2017-10-11	2019-04-18	Qpex Biopharma, Inc.	Boronic acid derivatives and synthesis thereof
CN109678856B (zh) *	2017-10-18	2020-09-25	新发药业有限公司	一种阿维巴坦中间体的制备方法
WO2019093450A1 (ja) *	2017-11-10	2019-05-16	塩野義製薬株式会社	ジアザビシクロオクタン誘導体
EP3781576B1 (en)	2018-04-20	2024-06-12	Qpex Biopharma, Inc.	Boronic acid derivatives and therapeutic uses thereof
US11905286B2 (en)	2018-08-09	2024-02-20	Antabio Sas	Diazabicyclooctanones as inhibitors of serine beta-lactamases
CN109942579B (zh) *	2019-04-18	2021-06-22	成都千禧莱医药科技有限公司	β-内酰胺酶抑制剂含脲双环化合物及其制备方法和应用
EP4146650A4 (en) *	2020-09-01	2024-01-17	Ningxia Academy of Agriculture and Forestry Sciences	BETA-LACTAMASE INHIBITORS AND THEIR PRODUCTION
WO2022047790A1 (en) *	2020-09-07	2022-03-10	Ningxia Academy Of Agriculture And Forestry Sciences	Amidine substituted bicyclic compounds, their preparation, their use as antibacterial agents and beta-lactamase inhibitors
WO2023060369A1 (en) *	2021-10-11	2023-04-20	Ningxia Academy Of Agriculture And Forestry Sciences	Novel carbimidate substituted bicyclic compounds and their use as beta-lactamase inhibitors
CN116375706A (zh) *	2023-02-22	2023-07-04	时森海(杭州)医药科技有限公司	阿维巴坦钠关键中间体及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0260057A3 (en)	1986-09-02	1989-02-01	The University Of Melbourne	2-oxo-4-carboxy-pyrimidines
DK0480939T3 (da)	1989-06-09	1995-07-10	Upjohn Co	Heterocycliske aminer med virkning på centralnervesystemet
FR2676230B1 (fr)	1991-05-07	1993-08-27	Centre Nat Rech Scient	Nouveaux derives de pyrrolo [1,4]-benzodiazepines, leur procede de preparation et medicaments les contenant.
JPH05339263A (ja)	1992-06-08	1993-12-21	Wakunaga Pharmaceut Co Ltd	ジヒドロピリジン誘導体
CA2173116C (en)	1993-09-29	2006-02-28	Barry Burns	Ring-expanded nucleosides and nucleotides
JP2895630B2 (ja) *	1993-12-29	1999-05-24	フアイザー・インコーポレイテツド	ジアザビシクロニューロキニンアンタゴニスト
EP0702004A2 (de) *	1994-09-15	1996-03-20	Ciba-Geigy Ag	2,9-Diamino- und 2-amino-8-carbamoyl-4-hydroxy-alkansäureamid-derivative
GB9505538D0 (en)	1995-03-18	1995-05-03	Ciba Geigy Ag	New compounds
SE9504618D0 (sv)	1995-12-22	1995-12-22	Astra Ab	New Compounds
EA199800525A1 (ru) *	1996-01-03	1999-02-25	Смитклайн Бичем Пи-Эл-Си	Карбамоилоксипроизводные мутилина и их применение в качестве антибактериальных средств
DE19627431A1 (de) *	1996-07-08	1998-01-15	Bayer Ag	Heterocyclisch kondensierte Pyridine
UA51716C2 (uk)	1996-07-08	2002-12-16	Авентіс Фармасьютікалз Продактс Інк.	Сполуки, що мають гіпотензивну, кардіопротекторну, анти-ішемічну та антиліполітичну властивості, фармацевтична композиція та способи лікування
HUP0001741A3 (en) *	1996-08-02	2000-11-28	Smithkline Beecham Plc	Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use, process for preparing them, pharmaceuticals contg. them and their use
TW527355B (en)	1997-07-02	2003-04-11	Bristol Myers Squibb Co	Inhibitors of farnesyl protein transferase
US5994340A (en) *	1997-08-29	1999-11-30	Synphar Laboratories, Inc.	Azetidinone derivatives as β-lactamase inhibitors
US6197339B1 (en)	1997-09-30	2001-03-06	Pharmacia & Upjohn Company	Sustained release tablet formulation to treat Parkinson's disease
UY25225A1 (es) *	1997-10-29	2000-12-29	Smithkline Beecham Plc	Derivados de pleuromutilina utiles como agentes antimicrobianos
CA2327695A1 (en)	1998-04-08	1999-10-21	Takeda Chemical Industries, Ltd.	Amine compounds, their production and their use as somatostatin receptor antagonists or agonists
EP1091944A1 (en)	1998-06-30	2001-04-18	Du Pont Pharmaceuticals Company	1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones useful as hiv reverse transcriptase inhibitors
GB9818731D0 (en)	1998-08-27	1998-10-21	Univ Portsmouth	Compounds
AU2347900A (en)	1998-12-18	2000-07-12	Schering Corporation	Farnesyl protein transferase inhibitors
CO5180550A1 (es)	1999-04-19	2002-07-30	Smithkline Beecham Corp	Inhibidores de fab i
AU7556800A (en)	1999-10-07	2001-05-10	Tadeka Chemical Industries, Ltd.	Amine derivatives
WO2001079206A1 (fr)	2000-04-18	2001-10-25	Sumitomo Pharmaceuticals Company, Limited	Quinazolinediones tricycliques
FR2812635B1 (fr) *	2000-08-01	2002-10-11	Aventis Pharma Sa	Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
ATE361750T1 (de)	2001-02-22	2007-06-15	Univ London Pharmacy	Indoline und tetrahydro-chinoline als prodrugs zur tumorbehandlung
FR2825705B1 (fr) *	2001-06-08	2005-05-20	Aventis Pharma Sa	Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
FR2835186B1 (fr) *	2002-01-28	2006-10-20	Aventis Pharma Sa	Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
US7439253B2 (en) *	2002-12-06	2008-10-21	Novexel	Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors

2002
- 2002-01-28 FR FR0200951A patent/FR2835186B1/fr not_active Expired - Lifetime
- 2002-12-29 JO JO2002138A patent/JO2646B1/en active
2003
- 2003-01-20 TW TW092101133A patent/TWI293071B/zh active
- 2003-01-27 NZ NZ533936A patent/NZ533936A/en not_active IP Right Cessation
- 2003-01-27 MY MYPI20030260A patent/MY140638A/en unknown
- 2003-01-27 MX MXPA04006621A patent/MXPA04006621A/es active IP Right Grant
- 2003-01-27 DE DE60334527T patent/DE60334527D1/de not_active Expired - Lifetime
- 2003-01-27 PE PE2003000080A patent/PE20030969A1/es active IP Right Grant
- 2003-01-27 CN CNA2008101667591A patent/CN101406471A/zh active Pending
- 2003-01-27 AR ARP030100226A patent/AR038234A1/es not_active Application Discontinuation
- 2003-01-27 RS YU65804A patent/RS52137B/en unknown
- 2003-01-27 OA OA1200400200A patent/OA12761A/fr unknown
- 2003-01-27 JP JP2003563554A patent/JP4472346B2/ja not_active Expired - Lifetime
- 2003-01-27 PT PT03709903T patent/PT1480644E/pt unknown
- 2003-01-27 AT AT03709903T patent/ATE484281T1/de active
- 2003-01-27 DK DK03709903.3T patent/DK1480644T3/da active
- 2003-01-27 ES ES03709903T patent/ES2356813T3/es not_active Expired - Lifetime
- 2003-01-27 SI SI200331935T patent/SI1480644T1/sl unknown
- 2003-01-27 ES ES10177533T patent/ES2401855T3/es not_active Expired - Lifetime
- 2003-01-27 WO PCT/FR2003/000243 patent/WO2003063864A2/fr active Application Filing
- 2003-01-27 UA UA20040807144A patent/UA80271C2/uk unknown
- 2003-01-27 CN CNB2007100015952A patent/CN100563653C/zh not_active Expired - Lifetime
- 2003-01-27 KR KR1020047011594A patent/KR100979079B1/ko active IP Right Grant
- 2003-01-27 SI SI200332240T patent/SI2279737T1/sl unknown
- 2003-01-27 UY UY27626A patent/UY27626A1/es not_active Application Discontinuation
- 2003-01-27 PL PL371601A patent/PL220725B1/pl unknown
- 2003-01-27 BR BRPI0307267A patent/BRPI0307267B8/pt active IP Right Grant
- 2003-01-27 DK DK10177533.6T patent/DK2279737T3/da active
- 2003-01-27 EA EA200400981A patent/EA007220B1/ru active Protection Beyond IP Right Term
- 2003-01-27 CN CNB038028786A patent/CN100482225C/zh not_active Expired - Lifetime
- 2003-01-27 PT PT101775336T patent/PT2279737E/pt unknown
- 2003-01-27 AU AU2003214335A patent/AU2003214335B2/en active Active
- 2003-01-27 EP EP03709903A patent/EP1480644B1/fr not_active Expired - Lifetime
- 2003-01-27 EP EP10177533A patent/EP2279737B1/fr not_active Expired - Lifetime
- 2003-01-27 CA CA2474043A patent/CA2474043C/fr not_active Expired - Lifetime
2004
- 2004-07-12 MA MA27777A patent/MA26351A1/fr unknown
- 2004-07-13 CR CR7387A patent/CR7387A/es unknown
- 2004-07-14 ZA ZA2004/05607A patent/ZA200405607B/en unknown
- 2004-07-15 EC EC2004005193A patent/ECSP045193A/es unknown
- 2004-07-22 IL IL163167A patent/IL163167A/en active Protection Beyond IP Right Term
- 2004-07-23 TN TNP2004000137A patent/TNSN04137A1/fr unknown
- 2004-07-26 US US10/898,754 patent/US7612087B2/en active Active
- 2004-07-26 CO CO04071440A patent/CO5601014A2/es not_active Application Discontinuation
- 2004-07-27 HR HRP20040686AA patent/HRP20040686B1/hr not_active IP Right Cessation
- 2004-08-27 NO NO20043587A patent/NO335195B1/no not_active IP Right Cessation
2005
- 2005-10-20 HK HK05109272.5A patent/HK1077205A1/xx not_active IP Right Cessation
2007
- 2007-10-17 HK HK07111190.8A patent/HK1105864A1/xx not_active IP Right Cessation
2009
- 2009-05-01 US US12/434,270 patent/US20090215747A1/en not_active Abandoned
- 2009-11-02 US US12/610,562 patent/US20100048528A1/en not_active Abandoned
2010
- 2010-12-23 CY CY20101101192T patent/CY1111061T1/el unknown
2011
- 2011-01-05 CL CL2011000009A patent/CL2011000009A1/es unknown
- 2011-06-16 US US13/161,783 patent/US20110245254A1/en not_active Abandoned
2012
- 2012-06-28 CR CR20120356A patent/CR20120356A/es unknown
2013
- 2013-01-31 CY CY20131100090T patent/CY1114417T1/el unknown
2015
- 2015-06-10 AR ARP150101838A patent/AR100790A2/es unknown
2016
- 2016-12-06 CY CY2016042C patent/CY2016042I1/el unknown
- 2016-12-08 NL NL300847C patent/NL300847I2/nl unknown
- 2016-12-12 BE BE2016C069C patent/BE2016C069I2/fr unknown
- 2016-12-13 LT LTPA2016037C patent/LTC1480644I2/lt unknown
- 2016-12-13 HU HUS1600055C patent/HUS1600055I1/hu unknown
- 2016-12-15 NO NO2016024C patent/NO2016024I1/no unknown

Also Published As

Publication number	Publication date
US20100048528A1 (en)	2010-02-25
BRPI0307267B1 (pt)	2016-02-10
CY2016042I2 (el)	2017-03-15
US20110245254A1 (en)	2011-10-06
UA80271C2 (uk)	2007-09-10
WO2003063864A3 (fr)	2004-03-11
HRP20040686A2 (en)	2004-12-31
DK2279737T3 (da)	2013-02-11
NO20043587L (no)	2004-08-27
EA007220B1 (ru)	2006-08-25
CY1111061T1 (el)	2015-06-11
LTC1480644I2 (lt)	2018-09-10
PT1480644E (pt)	2011-01-17
OA12761A (fr)	2006-07-04
EP2279737A1 (fr)	2011-02-02
BR0307267A (pt)	2004-12-07
PE20030969A1 (es)	2003-12-12
TW200303305A (en)	2003-09-01
KR100979079B1 (ko)	2010-08-31
JP4472346B2 (ja)	2010-06-02
SI2279737T1 (sl)	2013-07-31
LTPA2016037I1 (lt)	2017-01-10
CR7387A (es)	2010-10-25
CN100563653C (zh)	2009-12-02
HRP20040686B1 (hr)	2013-02-28
TNSN04137A1 (fr)	2007-03-12
MA26351A1 (fr)	2004-10-01
HUS1600055I1 (hu)	2017-01-30
DE60334527D1 (de)	2010-11-25
RS52137B (en)	2012-08-31
CY2016042I1 (el)	2017-03-15
ZA200405607B (en)	2005-09-28
CN101406471A (zh)	2009-04-15
CN1655781A (zh)	2005-08-17
CY1114417T1 (el)	2016-08-31
AU2003214335B2 (en)	2007-04-05
ES2401855T3 (es)	2013-04-25
CR20120356A (es)	2012-10-05
EP1480644A2 (fr)	2004-12-01
WO2003063864A2 (fr)	2003-08-07
AR038234A1 (es)	2005-01-05
TWI293071B (en)	2008-02-01
EP1480644B1 (fr)	2010-10-13
CO5601014A2 (es)	2006-01-31
AR100790A2 (es)	2016-11-02
NO2016024I2 (no)	2016-12-15
CL2011000009A1 (es)	2011-03-25
BRPI0307267B8 (pt)	2021-05-25
US20090215747A1 (en)	2009-08-27
NZ533936A (en)	2007-05-31
PT2279737E (pt)	2013-02-01
HK1077205A1 (en)	2006-02-10
KR20040081473A (ko)	2004-09-21
ES2356813T3 (es)	2011-04-13
DK1480644T3 (da)	2011-01-24
EP2279737B1 (fr)	2012-10-31
ATE484281T1 (de)	2010-10-15
CN100482225C (zh)	2009-04-29
EA200400981A1 (ru)	2005-02-24
YU65804A (sh)	2006-08-17
HK1105864A1 (en)	2008-02-29
JO2646B1 (en)	2012-06-17
NO2016024I1 (no)	2016-12-15
CN1994301A (zh)	2007-07-11
BE2016C069I2 (es)	2022-05-17
NL300847I2 (es)	2017-01-03
CA2474043A1 (fr)	2003-08-07
US20050020572A1 (en)	2005-01-27
FR2835186B1 (fr)	2006-10-20
SI1480644T1 (sl)	2011-03-31
PL371601A1 (en)	2005-06-27
PL220725B1 (pl)	2015-12-31
US7612087B2 (en)	2009-11-03
MXPA04006621A (es)	2004-10-04
NO335195B1 (no)	2014-10-20
JP2005523897A (ja)	2005-08-11
FR2835186A1 (fr)	2003-08-01
IL163167A (en)	2010-04-15
UY27626A1 (es)	2003-08-29
CA2474043C (fr)	2011-08-02
ECSP045193A (es)	2004-08-27

Publication	Publication Date	Title
MY140638A (en)	2010-01-15	New heterocyclic compounds, which are active as inhibitors of beta-lactamases
MX2010005299A (es)	2010-06-01	Derivados de bis-(sulfonilamino) en terapia 066.
MX2011012628A (es)	2011-12-14	Derivados amino-propionicos sustituidos como inhibidores de neprilisina.
TNSN08407A1 (en)	2010-04-14	Organic compounds
IN2012DN02465A (es)	2015-08-21
TW200626598A (en)	2006-08-01	Pyrrazolo-pyrimidine derivatives
MX2011012627A (es)	2011-12-14	Derivados aminobutiricos sustituidos como inhibidores de nepralisina.
SE0202462D0 (sv)	2002-08-14	Novel use
TW200728307A (en)	2007-08-01	Novel spirochromanone derivatives
HK1091121A1 (en)	2007-01-12	Substituted 2-aminotetralins for the treatment of depressions
GEP20125538B (en)	2012-05-25	2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2c antagonists for use in the treatment of peripheric and central nervous system diseases
NO20052182L (no)	2005-05-03	Nye forbindelser
ZA201002596B (en)	2010-12-29	1,2,3-triazole derivatives for use as stearoyl-coa destaurase inhibitors
MX2009009238A (es)	2009-09-08	Nuevos inhibidores de fosfodiesterasa.
TW200639156A (en)	2006-11-16	New compounds
UA97348C2 (en)	2012-02-10	HETEROCYCLIC NF-kB INHIBITORS
MX2009012125A (es)	2010-02-18	Compuestos terapeuticos.
SE0202429D0 (sv)	2002-08-14	Novel Compounds
MX2010001020A (es)	2010-03-01	Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas.
DE602004008959D1 (de)	2007-10-25	Benzoäbüä1,4üdioxepinderivate
MXPA05011176A (es)	2005-12-14	Derivados de carboxamida como agentes antidiabeticos.
MY140630A (en)	2010-01-15	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
TW200504029A (en)	2005-02-01	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
MXPA05005790A (es)	2005-10-18	Aminoalcoxiindoles como ligandos del receptor 5-ht6 para el tratamiento de enfermedades del sistema nervioso central.
TW200504030A (en)	2005-02-01	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof